BTIG Reiterates Buy on Compass Pathways, Maintains $14 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.0%

Neg 0% Neu 90% Pos 0%

BTIG analyst Thomas Shrader reiterates Compass Pathways (NASDAQ:CMPS) with a Buy and maintains $14 price target.

Comments

No comments yet. Be the first!